Ocular manifestations of drug abuse.
Abuse of drugs, including some used clinically and others with no legal or clinical use, can cause ocular injury and disease. Ocular manifestations of drug abuse may be due to the substances themselves, to invasive methods of administration, or to injury suffered during states of altered consciousness. Grouping the drugs into five categories (opiates, marijuana, stimulants, depressants and hallucinogens), the authors describe the pharmacologic, congenital, toxic, infectious, embolic, and psychological ocular manifestations of their abuse.
McLane
N J
NJ
Carroll
D M
DM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000818:Animals; D001424:Bacterial Infections / Q000209:etiology; D002177:Candidiasis / Q000209:etiology; D002188:Cannabis; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D009877:Endophthalmitis / Q000139:chemically induced / Q000209:etiology; D005123:Eye / Q000187:drug effects; D005124:Eye Abnormalities; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007231:Infant, Newborn; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000009:adverse effects; D011247:Pregnancy; D011803:Quinine / Q000009:adverse effects; D012164:Retinal Diseases / Q000139:chemically induced; D019966:Substance-Related Disorders / Q000150:complications*; D013472:Sunlight; D013627:Talc; D014149:Tranquilizing Agents / Q000009:adverse effects
D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D009294:Narcotics; D014149:Tranquilizing Agents; D013627:Talc; D008238:Lysergic Acid Diethylamide; D011803:Quinine